Stephanie E. Cohen

Pediatrics

300 1st Ave
Charlestown, MA 02129

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

MEASURING DOXYPEP USE RELATIVE TO STI RATES AT A SAN FRANCISCO STI CLINIC REVEALS RACIAL INEQUITIES IN DISEASE PREVENTION IMPACT.

MEASURING DOXYPEP USE RELATIVE TO STI RATES AT A SAN FRANCISCO STI CLINIC REVEALS RACIAL INEQUITIES IN DISEASE PREVENTION IMPACT.

Journal: Sexually transmitted diseases

Published: June 22, 2026

The Last Mile: Understanding Barriers to Hepatitis C Virus Microelimination Among People with HIV in San Francisco, 2021-2024.

The Last Mile: Understanding Barriers to Hepatitis C Virus Microelimination Among People with HIV in San Francisco, 2021-2024.

Journal: Open forum infectious diseases

Published: February 26, 2026

Syphilis and Cerebrospinal Fluid Examination-Reply.

Syphilis and Cerebrospinal Fluid Examination-Reply.

Journal: JAMA

Published: February 12, 2026

Diagnostic Dilemma: Pancreas Cancer vs Chronic Pancreatitis.

Diagnostic Dilemma: Pancreas Cancer vs Chronic Pancreatitis.

Journal: Surgical oncology clinics of North America

Published: November 13, 2025

Syphilis: A Review.

Syphilis: A Review.

Journal: JAMA

Published: October 16, 2025

Doxycycline Post-exposure Prophylaxis Awareness and Use Among Transgender Women in San Francisco, 2023-2024: Assessment One Year After Release of Health Department Guidance.

Doxycycline Post-exposure Prophylaxis Awareness and Use Among Transgender Women in San Francisco, 2023-2024: Assessment One Year After Release of Health Department Guidance.

Journal: AIDS and behavior

Published: September 21, 2025

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.

Journal: Lancet (London, England)

Published: June 09, 2025

Preexposure Prophylaxis Use Among Men Who Have Sex With Men With a History of Rectal Gonorrhea, Rectal Chlamydia, and/or Syphilis, STI Surveillance Network, 2021 to 2022.

Preexposure Prophylaxis Use Among Men Who Have Sex With Men With a History of Rectal Gonorrhea, Rectal Chlamydia, and/or Syphilis, STI Surveillance Network, 2021 to 2022.

Journal: Sexually transmitted diseases

Published: May 19, 2025

Rapid Diffusion of Awareness and Uptake of Doxy-PEP among Men who Have Sex with Men in San Francisco.

Rapid Diffusion of Awareness and Uptake of Doxy-PEP among Men who Have Sex with Men in San Francisco.

Journal: AIDS and behavior

Published: April 05, 2025

"It's Been a Very Liberating Experience": Doxycycline Postexposure Prophylaxis for Sexually Transmitted Infection Prevention and Experiences With Sexual Pleasure by Men Who Have Sex With Men.

"It's Been a Very Liberating Experience": Doxycycline Postexposure Prophylaxis for Sexually Transmitted Infection Prevention and Experiences With Sexual Pleasure by Men Who Have Sex With Men.

Journal: Sexually transmitted diseases

Published: April 01, 2025

Use of Doxycycline for Sexually Transmitted Infection Posteexposure Prophylaxis in People Assigned Female at Birth in the United States.

Use of Doxycycline for Sexually Transmitted Infection Posteexposure Prophylaxis in People Assigned Female at Birth in the United States.

Journal: Sexually transmitted diseases

Published: March 31, 2025

Routine Pharyngeal Gonorrhea Test of Cure: Is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy?

Routine Pharyngeal Gonorrhea Test of Cure: Is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy?

Journal: Sexually transmitted diseases

Published: March 14, 2025

Showing 1-12 of 104

Last Updated: 09/26/2026